3
Announcements
Trials
Browse
Landscape
Status
Recruiting
9
Completed
8
Active not recruiting
3
Unknown
2
Not yet recruiting
2
Withdrawn
1
Terminated
1
Sponsor Class
OTHER
2
Study Type
Observational
2
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Gynecologic
1
Conditions
Pelvic Organ Prolapse
1
Leukemia, Myeloid, Acute
1
Leiomyoma
1
Endometrial Hyperplasia
1
Interventions
Observation
21
Blood Specimen Collection
20
Drug Therapy
13
Surveys and Questionnaires
8
Surgical Procedures, Operative
8
Immunotherapy
7
Immune Checkpoint Inhibitors
7
Positron Emission Tomography Computed Tomography
5
Hematologic Tests
5
Watchful Waiting
4
Neoadjuvant Therapy
4
Fluorodeoxyglucose F18
4
Bevacizumab
4
darolutamide
3
Tyrosine Kinase Inhibitors
3
Therapeutics
3
Standard of Care
3
Radiotherapy
3
Indocyanine Green
3
Imatinib Mesylate
3
Endoscopic Mucosal Resection
3
Docetaxel
3
Cyclophosphamide
3
Capecitabine
3
Artificial Intelligence
3
tislelizumab
2
pertuzumab
2
palbociclib
2
obinutuzumab
2
nilotinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Observational
×
Restraint, Physical
×
Clear all
NCT07137299
2025-08-22
POP-LAP
Medical University of Silesia
Not yet recruiting
2,000 enrolled
NCT06786897
2025-01-22
ERAPH
University Hospital, Montpellier
Not yet recruiting
37 enrolled